The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Diabetic neuropathy and oxidative stress
Open accessAbstract
This review will focus on the impact of hyperglycemia-induced oxidative stress in the development of diabetes-related neural dysfunction. Oxidative stress occurs when the balance between the production of reactive oxygen species (ROS) and the ability of cells or tissues to detoxify the free radicals produced during metabolic activity is tilted in the favor of the former. Although hyperglycemia plays a key role in inducing oxidative stress in the diabetic nerve, the contribution of other factors, such as endoneurial hypoxia, transition metal imbalances, and hyperlipidemia have been also suggested. The possible sources for the overproduction of ROS in diabetes are widespread and include enzymatic pathways, auto-oxidation of glucose, and mitochondrial superoxide production. Increase in oxidative stress has clearly been shown to contribute to the pathology of neural and vascular dysfunction in diabetes. Potential therapies for preventing increased oxidative stress in diabetic nerve dysfunction will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
Bril, V., Buchanan, R. A., & the AS-3201 Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2369 · Cited by 87
THE SYMPATHETIC NERVOUS SYSTEM IN ALCOHOLIC NEUROPATHY: A CLINICAL AND PATHOLOGICAL STUDY
Low, P. A., WALSH, J. C., Huang, C. Y., & McLeod, J. G. (1975) · Brain · doi:10.1093/brain/98.3.357 · Cited by 86
Haffner, S. M., Agil, A., Mykkänen, L. M., D, M. P. S. M., & Jialal, I. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.646 · Cited by 83
Coppey, L. J., Gellett, J. S., Davidson, E. P., & Yorek, M. A. (2003) · Free Radical Research · doi:10.1080/1071576021000028442 · Cited by 82
Heesom, A. E., Millward, A., & Demaine, A. G. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.213 · Cited by 80
Non-enzymatic glycation of peripheral nerve proteins in human diabetics
Ryle, C., & Donaghy, M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00251-i · Cited by 78
Obrosova, I. G., Cao, X., Greene, D. A., & Stevens, M. (1998) · Diabetologia · doi:10.1007/s001250051090 · Cited by 78
Self-citationPiotrowski, P., Wierzbicka, K., & Śmiałek, M. (2001) · PubMed · Cited by 78
Role of Prostaglandin H2 as an Endothelium-Derived Contracting Factor in Diabetic State
Shimizu, K., Muramatsu, M., Kakegawa, Y., Asano, H., Toki, Y., Miyazaki, Y., Okumura, K., Hashimoto, H., & Ito, T. (1993) · Diabetes · doi:10.2337/diab.42.9.1246 · Cited by 75
Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
Kobayashi, M. S., Han, D., & Packer, L. (2000) · Free Radical Research · doi:10.1080/10715760000300121 · Cited by 75
Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy
Haak, E., Usadel, K. H., Kusterer, K., Amini, P., Frommeyer, R., Tritschler, H., & Haak, T. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7739 · Cited by 74
Antioxidant vitamins and their influence in diabetes mellitus
Hasanain, B., & Mooradian, A. D. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0110-6 · Cited by 74
Obrosova, I. G., Fathallah, L., Lang, H., & Greene, D. A. (1999) · Diabetologia · doi:10.1007/s001250051290 · Cited by 72
Sima, A., Zhang, W., Li, Z.-G., Murakawa, Y., & Pierson, C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1556 · Cited by 71
Self-citationMetabolic abnormalities in diabetic peripheral nerve: Relation to impaired function
Greene, D. A. (1983) · Metabolism · doi:10.1016/s0026-0495(83)80024-9 · Cited by 70
Stevens, M. J., Lattimer, S. A., Feldman, E. L., Helton, E. D., Millington, D. S., Sima, A. A. F., & Greene, D. A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90161-4 · Cited by 69
Self-citationAldose reductase inhibitors: An approach to the treatment of diabetic nerve damage
Greene, D. A., Sima, A. A. F., Stevens, M. J., Feldman, E. L., Killen, P. D., Henry, D., Thomas, T., Dananberg, J., & Lattimer, S. A. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090304 · Cited by 68
Self-citationKellogg, A. P., & Pop‐Busui, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1521 · Cited by 68
Self-citationEffect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
Scarpini, E. A., Sacilotto, G., Baron, P., Cusini, M., & Scarlato, G. (1997) · PubMed · Cited by 67
Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
Ng, T. F., Lee, F. K., Song, Z., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.6.961 · Cited by 66
Pierson, C. R., Zhang, W., & Sima, A. A. F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.765 · Cited by 66
Self-citationFaux, S. P., & Howden, P. J. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51127 · Cited by 65
Yamagishi, S., Uehara, K., Otsuki, S., & Yagihashi, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02011.x · Cited by 65
Gopaul, N. K., Nourooz‐Zadeh, J., Mallet, A. I., & Änggård, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00628-8 · Cited by 63
Function and Regulation of Prostaglandin Synthase-2
Herschman, H. R., Reddy, S. T., & Xie, W. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1813-0_9 · Cited by 63
Inhibition of Bile-Salt-Induced Hepatocyte Apoptosis by the Antioxidant Lazaroid U83836E
Patel, T. C., & Gores, G. J. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8031 · Cited by 62
Darley-Usmar, V. M., & White, R. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004026 · Cited by 59
Comparison of antioxidant activities of tocopherols alone and in pharmaceutical formulations
Mambro, V. M. D., Azzolini, A. E. C. S., Lucisano-Valim, Y. M., & Fonseca, M. J. V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00333-8 · Cited by 59
Trachtman, H., Futterweit, S., Prenner, J., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1235 · Cited by 55
3-Deoxyfructose Concentrations are Increased in Human Plasma and Urine in Diabetes
Wells‐Knecht, K. J., Lyons, T. J., McCance, D. R., Thorpe, S. R., Feather, M. S., & Baynes, J. (1994) · Diabetes · doi:10.2337/diab.43.9.1152 · Cited by 55
Interaction between osmotic and oxidative stress in diabetic precataractous lens
Obrosova, I. G., Fathallah, L., & Lang, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00315-9 · Cited by 54
The Use of Gamma Linolenic Acid in the Prevention and Treatment of Diabetic Neuropathy
JAMAL, G. A. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb02010.x · Cited by 54
MacRury, S. M., Gordon, D., Wilson, R., Bradley, H., Gemmell, C. G., Paterson, J. R., Rumleyd, A. G., & MacCuish, A. C. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00074.x · Cited by 52
Expression and localization of p53 and bcl‐2 in healing wounds in diabetic and nondiabetic mice
Kane, C. D., & Greenhalgh, D. G. (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00045.x · Cited by 52
Type 1 Diabetic Neuropathy and C‐peptide
Sima, A. A. F., Zhang, W., & Grunberger, G. (2003) · Journal of Diabetes Research · doi:10.1080/15438600490424541 · Cited by 51
Self-citationOxidative Protein Damage in Type I Diabetic Patients With and Without Complications
Çakatay, U., Telci, A., Salman, S., Satman, L., & Sıvas, A. (2000) · Endocrine Research · doi:10.3109/07435800009066174 · Cited by 51
L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain.
ONOFRJ, M. C., Fulgente, T., Melchionda, D., Marchionni, A., Tomasello, F. F., Salpietro, F. M., Alafaci, C., Sanctis, E. D., Pennisi, G., & Bella, R. (1995) · PubMed · Cited by 47
Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models.
Yagihashi, S. (1997) · PubMed · Cited by 47
Mitochondrial uncoupling proteins in human physiology and disease.
Hagen, T., & Vidal‐Puig, A. (2002) · PubMed · Cited by 47
Antioxidant Nutrients and Immune Functions - Introduction
Bendich, A. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0553-8_1 · Cited by 46
Miyauchi, Y., Shikama, H., Takasu, T., Okamiya, H., Umeda, M., Hirasaki, E., Ohata, I., Nakayama, H., & Nakagawa, S. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340467 · Cited by 44
Acetyl-L-carnitine for symptomatic diabetic neuropathy
Quatraro, A., Roca, P. B., Donzella, C., Acampora, R., Marfella, R., & Giugliano, D. (1995) · Diabetologia · doi:10.1007/bf02369363 · Cited by 43
Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B
Vega, G. L., Illingworth, D. R., Grundy, S. M., Lindgren, F. T., & Connor, W. E. (1983) · Metabolism · doi:10.1016/0026-0495(83)90215-9 · Cited by 41
Substrates for neural metabolism of xenobiotics in adult and developing brain.
Lowndes, H. E., Beiswanger, C. M., Philbert, M. A., & Reuhl, K. R. (1994) · PubMed · Cited by 41
Kador, P. F., Inoue, J., SECCHI, E. F., Lizak, M. J., Rodriguez, L., MORI, K., Greentree, W., BLESSING, K., Lackner, P. A., & Sato, S. (1998) · Experimental Eye Research · doi:10.1006/exer.1998.0502 · Cited by 40
Li, L., Shen, Y., Yang, X.-S., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02892-5 · Cited by 32
Vitamin E: The Evidence for Multiple Roles in Cancer
Sung, L., Greenberg, M., Koren, G., TOMLINSON, G. A., Tong, A., Malkin, D. M., & Feldman, B. M. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4601_01 · Cited by 30
Wascher, T. C., Toplak, H., Krejs, G. J., Simecek, S., Kukovetz, W. R., & Graier, W. F. (1994) · Diabetes · doi:10.2337/diab.43.8.984 · Cited by 29
The comparison of vitamin C and vitamin E on the protein oxidation of diabetic rats
Je, H. D., Shin, C. Y., Park, H. S., et al. (2001) · Journal of Autonomic Pharmacology · doi:10.1046/j.1365-2680.2001.00226.x · Cited by 28
Shimizu, S., Ishii, M., Momose, K., & Yamamoto, T. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2.5.533 · Cited by 28
Effect of Sorbitol Dehydrogenase Inhibition on Experimental Diabetic Autonomic Neuropathy
Schmidt, R. E., DORSEY, D. A., Beaudet, L. N., et al. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199812000-00010 · Cited by 27
Oldreive, C., Bradley, N. J., Bruckdorfer, R. K., & Rice-Evans, C. A. (2001) · Free Radical Research · doi:10.1080/10715760100300891 · Cited by 22
Nishigaki, R., Guo, F., Onda, M., et al. (1999) · Journal of Nippon Medical School · doi:10.1272/jnms.66.166 · Cited by 18
Insulin‐Like Growth Factor Replacement Therapy for Diabetic Neuropathy: Experimental Basis
Ishii, D. N., & Lupien, S. B. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.257 · Cited by 13
Cited by
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I. B., Robinson, N., Trence, D. L., Zelnick, L., & de Boer, I. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000991 · Cited by 162
Pop‐Busui, R., Lu, J., Lopes, N., & Jones, T. L. Z. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00200.x · Cited by 133
Self-citationYlitalo, K. R., Sowers, M., & Heeringa, S. (2011) · Diabetes Care · doi:10.2337/dc10-2150 · Cited by 85
Metadata
- Authors
- Pop-Busui, R., Sima, A., & Stevens, M.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2006
- Volume
- 22
- Issue
- 4
- Pages
- 257-273
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2091906768
- Cited by
- 286
- References
- 254
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
